The Role of PD-1 Checkpoint Inhibition in Gynecologic Malignancies
Sign Up to like & getrecommendations! Published in 2018 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-018-0593-2
Abstract: Opinion statementActivity of PD-1 and PD-L1 inhibitors has been demonstrated in ovarian, endometrial, and cervical cancer, with a tolerable side effect profile and the highest response rate seen in mismatch repair–deficient endometrial cancers. Other biomarkers… read more here.
Keywords: checkpoint inhibition; inhibition gynecologic; role checkpoint; gynecologic malignancies ... See more keywords